Severe ICANS after CAR T-cell therapy and assessment of prevention with levetiracetam for seizure prophylaxis following CAR T-cell for DLBCL & PMBCL in Europe: a survey on behalf of the Cellular Therapy & Immunobiology Working Party (CTIWP) of the EBMT

Piera Angelillo, Ana Alarcon Tomas, Edoardo Campodonico, Urban Novak, Ludovic Gabellier, Igor Wolfgang Blau, Mi Kwon, Ron Ram, Edouard Forcade, Caroline Besley, Vladan Vucinic, Nicolaus Kröger, Lucía López Corral, Jan Vydra, Silvia Ferrari, Bastian von Tresckow, Marie Therese Rubio, Rafael Hernani, Simona Sica, Friedrich StölzelMontserrat Rovira, Eva Wagner-Drouet, Jose Antonio Pérez-Simón, Cristina Castilla-Llorente, Andres J M Ferreri, Jorinde D Hoogenboom, Isabel Sanchez Ortega, Florent Malard, Jürgen Kuball, Annalisa Ruggeri*

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Pages (from-to)100-102
Number of pages3
JournalBone Marrow Transplantation
Volume60
Issue number1
Early online date25 Oct 2024
DOIs
Publication statusPublished - Jan 2025

Cite this